Vaccination for control and prevention of anthrax outbreaks

Anthrax is a serious disease caused by highly virulent spores of the bacterium Bacillus anthracis. If effective measures are not taken, anthrax can decimate herds of many farm animals, including cattle and horses.

Although the disease has become less common, thanks to an effective global eradication plan set up by the OIE and WHO, several cases have recently been reported during August and September in Spain.

This highly contagious disease, which is extremely easily transmitted to humans, among others, by simple skin contact, must be reported to the competent veterinary authorities.

What are the symptoms of this disease? How is this disease transmitted? What precautions should farmers take on a daily basis? What should be done if a case of anthrax is suspected in the herd? What solutions exist to treat and prevent the development of Bacillus Anthracis? These are some of the questions that RumiNews asked our veterinary expert in bovine and small ruminants, Raúl Martínez Fernández.

Find here his full interview and infographics on this disease : (in spanish)  La vacunación como medida de control y prevención del carbunco

You may also be interested in

30 January, 2025

Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium

Syva is pleased to announce that the FAMHP/FAGG has granted emergency use authorization for its marker (DIVA) vaccine against EHD in accordance with Article 110(2) of Regulation (EU) 2019/6 for use in cattle and deer.

Read more

24 January, 2025

Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health

We are pleased to remind you that the call for applications for the 28th Syva Award International is open until 18 February 2025. We also remind you that for two years now, the Syva Award International is no longer limited to Spanish candidates, but invites all doctoral students of any nationality who have submitted their thesis in animal health...

Read more

22 January, 2025

Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).

On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.

Read more